FI954064A - Stereoselektiivinen menetelmä dihydro-2,3-bensodiatsepiinijohdannaisten valmistamiseksi - Google Patents

Stereoselektiivinen menetelmä dihydro-2,3-bensodiatsepiinijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI954064A
FI954064A FI954064A FI954064A FI954064A FI 954064 A FI954064 A FI 954064A FI 954064 A FI954064 A FI 954064A FI 954064 A FI954064 A FI 954064A FI 954064 A FI954064 A FI 954064A
Authority
FI
Finland
Prior art keywords
dihydro
preparation
benzodiazepine derivatives
stereoselective method
stereoselective
Prior art date
Application number
FI954064A
Other languages
English (en)
Swedish (sv)
Other versions
FI954064A0 (fi
FI113269B (fi
Inventor
Benjamin Alan Anderson
Marvin Martin Hansen
Jeffrey Thomas Vincenzi
David Lee Varie
Jr Milton Joseph Zmijewski
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/413,036 external-priority patent/US5665878A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI954064A0 publication Critical patent/FI954064A0/fi
Publication of FI954064A publication Critical patent/FI954064A/fi
Application granted granted Critical
Publication of FI113269B publication Critical patent/FI113269B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI954064A 1994-08-31 1995-08-30 Menetelmä 8,9-dihydro-5-aryyli-7H-1,3-diokso[4,5-h][2,3-h]bentsodiatsepiinijohdannaisten valmistamiseksi FI113269B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29864594A 1994-08-31 1994-08-31
US29864594 1994-08-31
US08/413,036 US5665878A (en) 1994-08-31 1995-03-28 Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives
US41303695 1995-03-28

Publications (3)

Publication Number Publication Date
FI954064A0 FI954064A0 (fi) 1995-08-30
FI954064A true FI954064A (fi) 1996-03-01
FI113269B FI113269B (fi) 2004-03-31

Family

ID=26970799

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954064A FI113269B (fi) 1994-08-31 1995-08-30 Menetelmä 8,9-dihydro-5-aryyli-7H-1,3-diokso[4,5-h][2,3-h]bentsodiatsepiinijohdannaisten valmistamiseksi

Country Status (22)

Country Link
US (3) US5919954A (fi)
EP (1) EP0699677B1 (fi)
JP (1) JP3481019B2 (fi)
KR (1) KR100399518B1 (fi)
CN (1) CN1086705C (fi)
AT (1) ATE231867T1 (fi)
AU (1) AU702658B2 (fi)
BR (1) BR9503845A (fi)
CA (1) CA2157234C (fi)
CZ (1) CZ295675B6 (fi)
DE (1) DE69529499T2 (fi)
DK (1) DK0699677T3 (fi)
ES (1) ES2189819T3 (fi)
FI (1) FI113269B (fi)
HK (1) HK1013818A1 (fi)
HU (1) HU223776B1 (fi)
IL (1) IL115100A (fi)
IN (1) IN190402B (fi)
NO (1) NO312838B1 (fi)
PL (3) PL190640B1 (fi)
RU (1) RU2151149C1 (fi)
TR (1) TR199501071A2 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001512731A (ja) * 1997-08-12 2001-08-28 エギシュ ヂョヂセルヂャール エルテー ＡＭＰＡ／Ｋａｉｎａｔｅ受容体阻害剤としての１，３−ジオキソロ／４，５−Ｈ／２，３／ベンゾジアゼピン誘導体
UA67749C2 (uk) 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування
AU1302999A (en) * 1997-11-04 1999-05-24 Eli Lilly And Company Ketoreductase gene and protein from yeast
US20030219456A1 (en) * 2002-05-21 2003-11-27 Taing Ok Method of utilization of zygosaccharomyces rouxii
US6858605B2 (en) 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
ATE425817T1 (de) * 2005-12-05 2009-04-15 Deutsche Post Ag Verfahren zum sortieren von postsendungen und vorrichtung mit einer datenstruktur fur einen sortierplan
WO2007077469A1 (en) * 2005-12-30 2007-07-12 Egis Gyógyszergyár Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
KR100841592B1 (ko) 2007-04-16 2008-06-26 한양대학교 산학협력단 벤조디옥솔 유도체와 이의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794642A (en) * 1973-01-15 1974-02-26 Lilly Co Eli Oxidation of substituted methanes to the corresponding substituted methanols
DE2816475A1 (de) * 1978-04-15 1979-10-25 Bayer Ag Isochroman-derivate, verfahren zu ihrer herstellung und ihre verwendung als synergisten in insektiziden und akariziden mitteln
US4358041A (en) 1980-06-12 1982-11-09 Olin Corporation Powder-actuated tool with power adjustment and angle-fire control
HU191702B (en) * 1984-06-27 1987-03-30 Gyogyszerkutato Intezet New process for preparing 1-aryl-5 h-2,3-benzodiazepines
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU198494B (en) 1986-08-15 1989-10-30 Gyogyszerkutato Intezet Process for producing new 3,4-dihydro-5h-2,3-benzodiazepine derivative and acid addition salts thereof, as well as pharmaceutical compositions comprising same
DE68926417T2 (de) * 1988-02-12 1996-09-12 Daicel Chem Verfahren zur herstellung von optisch aktiven 2-hydroxysäureabkömmlingen
JP2679145B2 (ja) * 1988-09-02 1997-11-19 ダイセル化学工業株式会社 オキシケトンの製造法
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU206719B (en) 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
JP3061422B2 (ja) * 1990-12-27 2000-07-10 ダイセル化学工業株式会社 光学活性（ｓ）−２−クロロ−１−フェニルプロパノールの製造法
JPH04271789A (ja) * 1991-01-10 1992-09-28 Takeda Chem Ind Ltd Ｄ−パントラクトンの製造方法
HU219777B (hu) * 1993-07-02 2001-07-30 Gyógyszerkutató Intézet Kft. Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására

Also Published As

Publication number Publication date
NO953396D0 (no) 1995-08-30
NO953396L (no) 1996-03-01
DE69529499T2 (de) 2003-12-04
PL190640B1 (pl) 2005-12-30
FI954064A0 (fi) 1995-08-30
BR9503845A (pt) 1996-04-16
CA2157234A1 (en) 1996-03-01
JPH0881468A (ja) 1996-03-26
JP3481019B2 (ja) 2003-12-22
RU2151149C1 (ru) 2000-06-20
US5986114A (en) 1999-11-16
CZ295675B6 (cs) 2005-09-14
CZ221995A3 (en) 1996-03-13
CA2157234C (en) 2005-05-03
IL115100A0 (en) 1995-12-08
PL188796B1 (pl) 2005-04-29
US6160133A (en) 2000-12-12
HK1013818A1 (en) 1999-09-10
US5919954A (en) 1999-07-06
AU702658B2 (en) 1999-02-25
KR100399518B1 (ko) 2004-04-30
IN190402B (fi) 2003-07-26
HU9502545D0 (en) 1995-10-30
EP0699677A1 (en) 1996-03-06
ES2189819T3 (es) 2003-07-16
CN1123282A (zh) 1996-05-29
HUT72644A (en) 1996-05-28
FI113269B (fi) 2004-03-31
NO312838B1 (no) 2002-07-08
DK0699677T3 (da) 2003-04-22
DE69529499D1 (de) 2003-03-06
CN1086705C (zh) 2002-06-26
TR199501071A2 (tr) 1996-06-21
KR960007595A (ko) 1996-03-22
EP0699677B1 (en) 2003-01-29
AU3035595A (en) 1996-03-14
PL310226A1 (en) 1996-03-04
HU223776B1 (hu) 2005-01-28
ATE231867T1 (de) 2003-02-15
PL190318B1 (pl) 2005-11-30
IL115100A (en) 2000-07-26

Similar Documents

Publication Publication Date Title
PT778277E (pt) Derivados heterociclicos substituidos como antagonistas do crf
NO932870D0 (no) Ny fremgangsmaate for fremstilling av 9-amino-6-demetyl-6-deoksyetracykliner
ATE211732T1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
DE69527072T2 (de) Endothelin antagoniste
FI954064A (fi) Stereoselektiivinen menetelmä dihydro-2,3-bensodiatsepiinijohdannaisten valmistamiseksi
MY117754A (en) Stereoselective process for producing dihydro-2, 3-benzodiazepine derivatives
PT85570A (fr) Procede de preparation de derives de 2,3-dihydro furanne utilisables comme intermediaires pour la preparation de tetrahydrofuranne
MA23268A1 (fr) Procede de preparation de composes azacyliques heterocycliques utiles comme antagonistes des recepteurs d'natagonisne ii.
AU3210593A (en) Improvements in or relating to organic compounds
PL340756A1 (en) Novel heterocyclic ring substituted derivatives of alpha-hydroxycarboxylic acid, method of obtaining said derivatives and their application as antagonists of endoethelin receptor
HUP9904069A2 (hu) Eljárás 5alfa-reduktáz inhibitor benzo[f]kinolinon-származékok előállítására, intermedierjeik és előállításuk
AU1392600A (en) Alkyl esters of 3-(3,4-dihalogenophenyl)-2,6-dioxopiperidine-3-propionic acid useful as intermediates
DK0949250T3 (da) Fremgangsmåde til fremstilling af alpha1L-adrenoceptorantagonister